PVLA Palvella Therapeutics Inc

12.49

-0.50 (-3.85%)

25 Jan 2025 - Closed

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type
Palvella Therapeutics Inc	NASDAQ:PVLA	NASDAQ	Common Stock

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	-0.50	-3.85%	12.49	11.83	15.50	13.18	12.10	12.80	17,759	01:00:00

Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership

20/12/2024 10:32pm

Edgar (US Regulatory)

EXHIBIT 1

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the Common Stock of Palvella Therapeutics, Inc. and that this Agreement be included as an Exhibit to such joint filing. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

IN WITNESS WHEREOF, the undersigned hereby execute this Agreement this [__] day of December, 2024.


	Name: Wesley H. Kaupinen


	Wesley H. Kaupinen 2019 Irrevocable Trust dated February 28, 2019


	By:
		Name: Christine L. Kaupinen
		Title: Trustee



	Name: Christine L. Kaupinen


	Christine L. Kaupinen 2019 Irrevocable Trust dated February 28, 2019


	By:
		Name: Michael Christopher
		Title: Trustee



		Name: Michael Christopher